Sep 29, 2020 | News, Press Release
Hemanext to Present New Red Blood Cell Research Data at AABB 2020 Four abstracts add to the growing body of evidence supporting hypoxic storage of RBCs LEXINGTON, Mass., September 29, 2020 Hemanext Inc., a privately held medical technology company dedicated to...
Jul 6, 2020 | News, Press Release
Celebrating David Herman (1946 – 2020) With deep sadness, we record the untimely death in London on June 3rd of our fellow Board Director, investor and friend, David Herman. David served Hemanext as a member of the board for 10 years. He brought to this role a...
Jun 17, 2020 | News, Press Release
Join Us June 19th! Help Shine the Light on Sickle Cell Disease On June 19th, people around the globe will come together to recognize the United Nation’s World Sickle Cell Awareness Day through a wide variety of online activities. The celebration is called Shine the...
Jun 10, 2020 | News, Press Release
Thalassaemia International Federation and Hemanext® Inc. Announce New Strategic Alliance Organizations create partnership to support the needs of people living with hemoglobin disorders NICOSIA, Cyprus and LEXINGTON, Mass., June 10, 2020 The Thalassaemia International...
May 7, 2020 | News, Press Release
Sickle Cell Disease Association of America, Inc. and Hemanext® Inc. Form New Strategic Partnership New alliance designed to enhance the lives of people living with sickle cell disease HANOVER, Md. and LEXINGTON, Mass., May 6, 2020 Sickle Cell Disease Association of...
Nov 1, 2019 | News, Press Release
Hemanext Announces CE Mark Submission for the HEMANEXT ONE Red Blood Cell Processing System Regulatory filing is a major step toward commercialization of transfusion-medicine innovation LEXINGTON, Mass., November 1, 2019 Hemanext Inc., a privately held medical...
